Clinical Cancer Research, Vol 1, Issue 12 1557-1562, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor

BD Kavanagh, PS Lin, P Chen and RK Schmidt-Ullrich
Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0058, USA.

Ionizing radiation is believed to stimulate the repopulation of squamous carcinoma cells that survive the early portion of a fractionated course of radiotherapy. To characterize any intrinsic radiation-induced adaptive response and to examine whether epidermal growth factor (EGF) influences this response, A431 and 183A cells were irradiated with repeated daily exposures of 0.5-0.75 Gy and then grown in monolayer culture for 7 days with or without EGF at a 1 ng/ml concentration. Cell numbers were quantified using a microtiter dye-reduction assay. EGF alone caused approximately 70% and 30% growth inhibition of human SC A431 and 183A cells, respectively. Although radiation alone did not affect proliferative rates in these conditions, radiation eliminated the EGF-related growth inhibition in both cell lines. This effect was dose dependent in single radiation exposure experiments. Cell cycle analyses indicated that EGF initially promoted entry into S-phase 3 days after treatment but caused a G1-S block after 7 days. Treatment with radiation recruited cells into S-phase and G2-M, an effect which was sustained 7 days after treatment, overriding the influence of EGF. Radiation-induced modulation of the response of human squamous carcinoma cells to EGF in vitro after single and repeated radiation exposures suggests a proliferation response that may underlie enhanced repopulation of tumor clonogens in vivo.

This article has been cited by other articles:

				H.-C. Lee, S. An, H. Lee, S.-H. Woo, H.-O. Jin, S.-K. Seo, T.-B. Choe, D.-H. Yoo, S.-J. Lee, Y.-J. Hong, et al. Activation of Epidermal Growth Factor Receptor and Its Downstream Signaling Pathway by Nitric Oxide in Response to Ionizing Radiation Mol. Cancer Res., June 1, 2008; 6(6): 996 - 1002. [Abstract] [Full Text] [PDF]

				P. M. Harari, G. W. Allen, and J. A. Bonner Biology of Interactions: Antiepidermal Growth Factor Receptor Agents J. Clin. Oncol., September 10, 2007; 25(26): 4057 - 4065. [Abstract] [Full Text] [PDF]

				G. Lammering, T. H. Hewit, M. Holmes, K. Valerie, W. Hawkins, P.-S. Lin, R. B. Mikkelsen, and R. K. Schmidt-Ullrich Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity Clin. Cancer Res., October 1, 2004; 10(19): 6732 - 6743. [Abstract] [Full Text] [PDF]

				A J Colquhoun and J K Mellon Epidermal growth factor receptor and bladder cancer Postgrad. Med. J., October 1, 2002; 78(924): 584 - 589. [Abstract] [Full Text] [PDF]

				G. P. Amorino, V. M. Hamilton, K. Valerie, P. Dent, G. Lammering, and R. K. Schmidt-Ullrich Epidermal Growth Factor Receptor Dependence of Radiation-induced Transcription Factor Activation in Human Breast Carcinoma Cells Mol. Biol. Cell, July 1, 2002; 13(7): 2233 - 2244. [Abstract] [Full Text] [PDF]

				G. Lammering, T. H. Hewit, W. T. Hawkins, J. N. Contessa, D. B. Reardon, P.-S. Lin, K. Valerie, P. Dent, R. B. Mikkelsen, and R. K. Schmidt-Ullrich Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization J Natl Cancer Inst, June 20, 2001; 93(12): 921 - 929. [Abstract] [Full Text] [PDF]

				G. Lammering, K. Valerie, P.-S. Lin, R. B. Mikkelsen, J. N. Contessa, J. P. Feden, J. Farnsworth, P. Dent, and R. K. Schmidt-Ullrich Radiosensitization of Malignant Glioma Cells through Overexpression of Dominant-Negative Epidermal Growth Factor Receptor Clin. Cancer Res., March 1, 2001; 7(3): 682 - 690. [Abstract] [Full Text]

				J. N. Contessa, D. B. Reardon, D. Todd, P. Dent, R. B. Mikkelsen, K. Valerie, G. D. Bowers, and R. K. Schmidt-Ullrich The Inducible Expression of Dominant-Negative Epidermal Growth Factor Receptor-CD533 Results in Radiosensitization of Human Mammary Carcinoma Cells Clin. Cancer Res., February 1, 1999; 5(2): 405 - 411. [Abstract] [Full Text] [PDF]

				N. Gueven, K. E. Keating, P. Chen, T. Fukao, K. K. Khanna, D. Watters, P. H. Rodemann, and M. F. Lavin Epidermal Growth Factor Sensitizes Cells to Ionizing Radiation by Down-regulating Protein Mutated in Ataxia-Telangiectasia J. Biol. Chem., March 16, 2001; 276(12): 8884 - 8891. [Abstract] [Full Text] [PDF]